Severe sepsis Trials in Boston, United States
Conditions / Severe sepsis / Boston, United States
Severe sepsis has been the subject of sustained clinical investigation across multiple research sites.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00793442 | Endothelium in Severe Sepsis | COMPLETED | — |
| NCT01486524 | Pharmacogenomic Biomarker Study for Recombinant Human Activated Protein C Treatment in Severe Sepsis | UNKNOWN | — |
| NCT02960854 | A Study of Nivolumab Safety and Pharmacokinetics in Patients With Severe Sepsis or Septic Shock. | COMPLETED | PHASE1 |
| NCT01449721 | Preemptive Resuscitation for Eradication of Septic Shock | COMPLETED | NA |
| NCT00448968 | The Utility of Ischemia Modified Albumin (IMA) in Sepsis | COMPLETED | — |
| NCT00334828 | ACCESS: A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients With Severe Sepsis | COMPLETED | PHASE3 |
| NCT00510835 | Protocolized Care for Early Septic Shock | COMPLETED | NA |
| NCT02576457 | Safety, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Severe Sepsis | TERMINATED | PHASE1 |
| NCT01523717 | Procalcitonin Monitoring Sepsis Study | COMPLETED | — |
| NCT00372502 | Clinical Trial of the Optimal Endpoint of Early Sepsis Resuscitation | COMPLETED | NA |